Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiopulmonary Bypass: full-pipeline trial registry
3 of 12 indexed Cardiopulmonary Bypass trials are currently recruiting.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 3 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Cardiopulmonary Bypass: 12 US clinical trials tracked, 3 recruiting.
Cardiopulmonary Bypass is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Xijing Hospital, running 1 of these trials.
Enrollment posture brief
Registry condition cardiopulmonary-bypass
OPEN 3 | RECR 25% | LATE 3 | EARLY 2 | RANK #1429 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Cardiopulmonary Bypass lists 3 open slots (25% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiopulmonary Bypass on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiopulmonary Bypass is recruiting below its size-band peers.
3 of 12 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cardiopulmonary Bypass trials is spread across many organizations.
Xijing Hospital accounts for 1 of 12 trials (8.3%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiopulmonary Bypass enrolment sits around 300 participants.
Median target enrolment is 300 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.
-
Cardiopulmonary Bypass splits between interventional and observational designs.
7 interventional and 5 observational studies make up this index (58.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
Xijing Hospital
NCT06702553
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
University of Maryland, Baltimore
NCT05189262
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Sophia Koutsogiannaki
NCT04296071
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Alexion Pharmaceuticals
NCT05746559
Impact of Pulsatile Cardio-Pulmonary Bypass (CPB) on Vital Organ Recovery
Milton S. Hershey Medical Center
NCT00862407
Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery
University of Arkansas
NCT00569855
Understanding "Heparin Resistance" in Cardiac Surgery
Massachusetts General Hospital
NCT01598883
Cerebral Autoregulation Monitoring During Cardiac Surgery
Northwestern University
NCT00981474
Aprotinin in Neonates Undergoing Cardiopulmonary Bypass
Children's Healthcare of Atlanta
NCT00469742
SPY Imaging System: Its Role in Pediatric Cardiac Surgery
Emory University
NCT00446927
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
Vanderbilt University Medical Center
NCT01228305
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Baxter Healthcare Corporation
NCT00161733
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiopulmonary Bypass records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiopulmonary Bypass trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiopulmonary Bypass page
12 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Cardiopulmonary Bypass trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Xijing Hospital sponsors the most Cardiopulmonary Bypass trials on record, review their full trial history before evaluating a specific study. See Xijing Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiopulmonary Bypass condition card totals 12 registered trials; most-linked intervention TISSEEL VH fibrin sealant; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.